GS-100 ɛ recombinant AAV9 vector mi̱ la NGLY1 ji̱i̱n ran. Jɛn cɛ jek ɛ la wal ti̱ /thiɛl gua̱a̱thdiɛn kä US Food and Drug Administration kɛnɛ European Medicine Agency (EMA) Kä therapi̱ bɔ̱ cɛ jek ɛ la FDA's rare paediatric disease designation rɛy 2021 kɛnɛ pɛ̈thdɛ kɛ jäldɛ kɛ ruɔ̱n ëë ci̱ wɔ̱.